Brackenridge's Medical Selection of Life Risks
The sixth edition of this leading reference book on insurance medicine provides a comprehensive guide to life expectancy for underwriters and clinicians involved in the life insurance industry. Extensively revised and expanded, the new edition reflects developments in life and healthcare insurance as well as medicine. Almost 20 years since it's last edition, each chapter is significantly updated to include the latest advancements in each disease, risk selection, and classification. Additionally, new content has been added to include rare disorders, the impact of climate and environmental changes on insurance medicine, screening for diseases and risk of disease, and critical illness. The impact of AI and other advanced technologies is also be discussed.
Daniel D. Zimmerman, M.D., is Senior Vice President and Chief Science Advisor for RGA Reinsurance Company. Additionally, he serves as editor of ReFlections, RGA’s global medical newsletter. He is also Managing Director of The Longer Life Foundation. Before joining RGA in 2014, Dr. Zimmerman was a medical director with Northwestern Mutual Life Insurance Company for 8 years. Previously, he practiced primary care internal medicine and pediatrics in Tampa, Florida.
Rodney C. Richie, M.D., is the Editor-in-Chief of the American Academy of Insurance Medicine's Journal of Insurance Medicine. He is a past medical director of both the Texas Life Insurance Company and EMSI. He has been an active member of the American Academic of Insurance Medicine (AAIM) for almost four decades.
Michael L. Moore, M.D., is Chief Medical Director of Nationwide Insurance in Columbus, Ohio.
Ross MacKenzie, M.D., is the current Editor Emeritus of the American Academy of Insurance Medicine's Journal of Insurance Medicine. Dr. MacKenzie spent most of his career as a board-certified cardiologist in Canada.